SmPC-Zercepac 60 mg powder for concentrate for solution for infusion: Change history
View Summary of Product Characteristics (SmPC-Zercepac 60 mg powder for concentrate for solution for infusion)
Last updated on this site: 31 Jul 2026
Description of update: To update SmPC sections 2, 4.4 and 6.1 and the PIL in line with the reference product information (reference product: Herceptin). Consequently, the PIL has been updated.
Date of approval: 20/07/2026
SmPC sections updated: 2, 4.4, 6.1 and 10
Last updated on this site: 31 Jul 2026
Description of update: To update SmPC sections 2, 4.4 and 6.1 and the PIL in line with the reference product information (reference product: Herceptin). Consequently, the PIL has been updated.
Date of approval: 20/07/2026
SmPC sections updated: 2, 4.4, 6.1 and 10
-
Changes: (Updated: 31 Jul 2026)
Description of update: To update SmPC sections 2, 4.4 and 6.1 and the PIL in line with the reference product information (reference product: Herceptin). Consequently, the PIL has been updated.
Date of approval: 20/07/2026
SmPC sections updated: 2, 4.4, 6.1 and 10
-
Changes: (Updated: 25 Feb 2025)
Renewal Approval
-
Changes: (Updated: 04 Sep 2023)
To register a change in the ATC code following a WHO Recommendation from "L01XC03" to "L01FD01." Consequentially, section 5.1 of the SmPC has been updated.
-
Changes: (Updated: 08 Dec 2022)
Updated document from Word to PDF
-
Changes: (Updated: 08 Dec 2022)
Initial upload